10 employees
Onconetics Pharmaceuticals develops personalized gene therapies for cancers and other genetic disorders.
2016
Onconetics Pharmaceuticals, Inc. raised undisclosed on October 5, 2017
Investors: IndieBio and SOSV - The Accelerator VC